The m6A demethylase FTO promotes C/ EBPβ ‐ LIP translation to perform oncogenic functions in breast cancer cells
The FEBS Journal · 2025
DOI: 10.1111/febs.70033 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Hidde R Zuidhof und 6 weiteren Autor:innen. Beteiligte Einrichtung: European Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen, University of Groningen, The Netherlands. Hauptthemen laut MEDLINE: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, CCAAT-Enhancer-Binding Protein-beta, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, KWF Kankerbestrijding, Boehringer Ingelheim.
Abstract (Originalsprache)
N6‐methyladenosine (m6A) is a prevalent posttranscriptional mRNA modification involved in the regulation of transcript turnover, translation, and other aspects of RNA fate. The modification is mediated by multicomponent methyltransferase complexes (so‐called writers) and is reversed through the action of the m6A‐demethylases fat mass and obesity‐associated (FTO) and alkB homolog 5 (ALKBH5) (so‐called erasers). FTO promotes cell proliferation, colony formation and metastasis in models of triple‐negative breast cancer (TNBC). However, little is known about genome‐wide or specific downstream regulation by FTO. Here, we examined changes in the genome‐wide transcriptome and translatome following FTO knockdown in TNBC cells. Unexpectedly, FTO knockdown had a limited effect on the translatome, while transcriptome analysis revealed that genes related to extracellular matrix (ECM) and epithelial‐mesenchymal transition (EMT) are regulated through yet unidentified mechanisms. Differential translation of CEBPB mRNA into the C/EBPβ transcription factor isoform C/EBPβ‐LIP is known to act in a pro‐oncogenic manner in TNBC cells through regulation of EMT genes. Here we show that FTO is required for efficient C/EBPβ‐LIP expression, suggesting that FTO has oncogenic functions through regulation of C/EBPβ‐LIP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- European Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen, University of Groningen, The Netherlands.
- Translational Control and Metabolism, German Cancer Research Center (DKFZ), Heidelberg, Germany.
ORCID-Profile: Cornelis F Calkhoven
Förderung
- Deutsche Forschungsgemeinschaft
- KWF Kankerbestrijding
- Boehringer Ingelheim
- European Research Council
Zitieren
APA
Zuidhof, H. R., Müller, C., Kortman, G., Wardenaar, R., Stepanova, E., Loayza-Puch, F., & Calkhoven, C. F. (2025). The m6A demethylase FTO promotes C/ EBPβ ‐ LIP translation to perform oncogenic functions in breast cancer cells. The FEBS Journal. https://doi.org/10.1111/febs.70033
Vancouver
Zuidhof HR, Müller C, Kortman G, Wardenaar R, Stepanova E, Loayza-Puch F, et al. The m6A demethylase FTO promotes C/ EBPβ ‐ LIP translation to perform oncogenic functions in breast cancer cells. The FEBS Journal. 2025. doi:10.1111/febs.70033
BibTeX
@article{Zuidhof2025,
author = {Zuidhof, Hidde R and Müller, Christine and Kortman, Gertrud and Wardenaar, René and Stepanova, Ekaterina and Loayza-Puch, Fabricio and Calkhoven, Cornelis F},
title = {The m6A demethylase FTO promotes C/ EBPβ ‐ LIP translation to perform oncogenic functions in breast cancer cells},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70033}
}
EUVIMED